Capsoni, 52 patient HCQ late treatment study: 40% lower ventilation [p=0.3] https://c19p.org/capsoni
copied to clipboard
CPAP Treatment In COVID-19 Patients: A Retrospective Observational Study In The Emergency Department
et al., Research Square, doi:10.21203/rs.3.rs-113418/v1 (Preprint)
Small 52 patient retrospective study of patients with acute respiratory failure showing lower rates of intubation with HCQ.
|
risk of mechanical ventilation, 40.0% lower, RR 0.60, p = 0.30, treatment 12 of 40 (30.0%), control 6 of 12 (50.0%), NNT 5.0.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Capsoni et al., 12/1/2020, retrospective, Italy, Europe, preprint, 13 authors, average treatment delay 7.0 days.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.